Medgenics Company Profile (NASDAQ:MDGN)

About Medgenics (NASDAQ:MDGN)

Medgenics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:MDGN
  • CUSIP: N/A
  • Web: www.medgenics.com
Average Prices:
  • 50 Day Moving Avg: $5.23
  • 200 Day Moving Avg: $5.54
  • 52 Week Range: $3.09 - $6.60
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.35
  • P/E Growth: 0.00
Profitability:
  • Return on Equity: -85.70%
  • Return on Assets: -78.57%
Debt:
  • Current Ratio: 8.71%
  • Quick Ratio: 8.71%
Misc:
  • Average Volume: 185,272 shs.
  • Beta: 1.17
 

Frequently Asked Questions for Medgenics (NASDAQ:MDGN)

What is Medgenics' stock symbol?

Medgenics trades on the NASDAQ under the ticker symbol "MDGN."

How were Medgenics' earnings last quarter?

Medgenics Inc (NASDAQ:MDGN) released its quarterly earnings data on Thursday, August, 4th. The company reported ($0.69) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.39. View Medgenics' Earnings History.

When will Medgenics make its next earnings announcement?

Medgenics is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Medgenics.

Where is Medgenics' stock going? Where will Medgenics' stock price be in 2017?

3 brokers have issued 12 month price objectives for Medgenics' stock. Their forecasts range from $14.00 to $14.00. On average, they expect Medgenics' stock price to reach $14.00 in the next year. View Analyst Ratings for Medgenics.

Who are some of Medgenics' key competitors?

How do I buy Medgenics stock?

Shares of Medgenics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medgenics' stock price today?

One share of Medgenics stock can currently be purchased for approximately $5.57.


MarketBeat Community Rating for Medgenics (NASDAQ MDGN)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about Medgenics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medgenics (NASDAQ:MDGN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (151.35% upside)

Analysts' Ratings History for Medgenics (NASDAQ:MDGN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/6/2016HC WainwrightInitiated CoverageBuy$14.00N/AView Rating Details
11/4/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
9/23/2016Jefferies Group LLCInitiated CoverageBuyN/AView Rating Details
6/7/2016Needham & Company LLCReiterated RatingBuy$12.00N/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Medgenics (NASDAQ:MDGN)
Earnings by Quarter for Medgenics (NASDAQ:MDGN)
Earnings History by Quarter for Medgenics (NASDAQ MDGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017N/AView Earnings Details
11/3/2016Q316($0.30)($0.29)ViewN/AView Earnings Details
8/4/2016Q2($0.30)($0.69)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medgenics (NASDAQ:MDGN)
Current Year EPS Consensus Estimate: $-1.26 EPS
Next Year EPS Consensus Estimate: $-1.28 EPS

Dividends

Dividend History for Medgenics (NASDAQ:MDGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medgenics (NASDAQ:MDGN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Medgenics (NASDAQ:MDGN)
Latest Headlines for Medgenics (NASDAQ:MDGN)
Source:
DateHeadline
americanbankingnews.com logoMedgenics Inc (MDGN) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 26 at 7:12 AM
americanbankingnews.com logoMedgenics (MDGN) Getting Somewhat Positive Media Coverage, Analysis Shows
www.americanbankingnews.com - April 30 at 8:28 AM
americanbankingnews.com logoMedgenics (MDGN) Receives Daily Media Impact Score of -0.22
www.americanbankingnews.com - April 24 at 1:58 PM
americanbankingnews.com logoMedgenics (MDGN) Receiving Somewhat Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 21 at 12:14 AM
americanbankingnews.com logoMedgenics (MDGN) Receiving Somewhat Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 17 at 3:54 PM
finance.yahoo.com logoCoverage initiated on Medgenics by H.C. Wainwright
finance.yahoo.com - December 6 at 9:58 AM
cnbc.com logoMedgenics reports 3Q loss
www.cnbc.com - November 3 at 6:07 PM
biz.yahoo.com logoMEDGENICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - November 3 at 6:07 PM
rttnews.com logoILMN Fails To Light Up, MDGN Leaves The Big Board For Nasdaq, Watch Out For SUPN
www.rttnews.com - October 11 at 6:22 PM
finance.yahoo.com logoMDGN: Several Upcoming Milestones Including NFC-1 ADHD Phase 2/3 Data
finance.yahoo.com - August 9 at 6:21 PM

Social

Chart

Medgenics (MDGN) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff